Dementia Treatment: A Complete Guide

Dementia Treatment: A Complete Guide
Everyday Health
Different types of dementia, or advanced cognitive impairment that disrupts daily functioning, respond to different treatment approaches. Medications and nondrug interventions can both help reduce symptoms and improve a person’s quality of life, and some treatments have been shown to slow the cognitive decline process in some people. But for most dementia types, no treatment can cure the underlying brain disorder or reverse the process of cognitive decline.



Medications for Cognitive Symptoms

Most treatments for dementia have been developed for and studied in people with Alzheimer’s disease, the most common form of dementia. But doctors often prescribe some of the FDA-approved drugs for Alzheimer’s disease to people with other forms of dementia.

Here are the main types of drugs used to treat the cognitive symptoms of Alzheimer’s and other dementia types.

Cholinesterase Inhibitors

This category of medications works by preventing the breakdown of a brain chemical called acetylcholine, which is important for memory and learning.

 It includes the following drugs:
  • donepezil (Aricept)
  • galantamine (Razadyne)
  • rivastigmine (Exelon)
  • benzgalantamine (Zunveyl)
These drugs support communication between nerve cells (neurons) in your brain and can help people who are experiencing mild to moderate problems with memory, motivation, or concentration. But they don’t change the course of dementia progression.

When given in the early stages of Alzheimer’s, Lewy body dementia, vascular dementia, or mixed dementia, such as when someone has both Alzheimer’s and vascular dementia, “they’re effective at helping maintain cognitive function for maybe 6 to 18 months,” says Freddi Segal-Gidan, a certified physician assistant at Keck Medicine of the University of Southern California Memory and Aging Center in Los Angeles.

Cholinesterase inhibitors are commonly prescribed to people with Lewy body dementia to help with disturbing hallucinations or troubling behaviors. Some researchers believe that people with Lewy body dementia may see even more improvement than those with Alzheimer’s.

Cholinesterase inhibitors are not recommended for frontotemporal dementia and can even make symptoms worse. There are currently no treatments for cognitive symptoms in people with frontotemporal dementia.

Glutamate Regulators

Memantine (Namenda) works by regulating a chemical messenger in the brain called glutamate, which helps with information processing. It’s prescribed to help improve memory, attention, reasoning, and language.

It’s common, Segal-Gidan says, for a person with dementia to start taking a cholinesterase inhibitor and then, after a year or two, add memantine. But if a person can’t tolerate cholinesterase inhibitors due to side effects like nausea or diarrhea, they might take memantine instead.

Anti-Amyloid Drugs

These medications for Alzheimer’s work by removing a protein called beta-amyloid, which is involved in plaque accumulation in the brain. Unlike drugs that address cognitive symptoms but not the underlying disease, anti-amyloid drugs may change the course of Alzheimer’s in a meaningful way when given in the early stages.

Anti-amyloid drugs include the following:

  • donanemab (Kisunla)
  • lecanemab (Leqembi)
These drugs have been shown to somewhat slow cognitive decline in people with Alzheimer’s disease. They are given by IV infusion every two to four weeks, depending on the drug.

But anti-amyloid drugs don’t work for everyone, and healthcare providers are still figuring out how to use them in the most effective way. “There’s a lot we don’t know about these drugs,” says Segal-Gidan, because they are new and the clinical trials that led to their approval had limited durations.

What’s more, anti-amyloid drugs require brain MRIs to monitor for swelling or bleeding, which are known side effects. In rare cases, brain swelling may cause seizures or other symptoms. Other possible side effects following infusions include nausea, vomiting, and dizziness.

Lifestyle Changes for Dementia

Certain healthy lifestyle patterns may help reduce your risk of developing dementia. It’s less clear how helpful these lifestyle changes are once you’ve received a dementia diagnosis, but it’s possible they could help limit further cognitive decline, especially if you have mild cognitive impairment, which is less severe than dementia.

The following lifestyle changes may help prevent or reduce cognitive decline:

  • Maintain a healthy weight. Overweight and obesity are linked to diabetes and cardiovascular disease, which can raise your dementia risk.
  • Get physical activity. Staying active can help prevent cardiovascular problems linked to dementia.
  • Keep your mind engaged. Mentally challenging activities may help limit cognitive decline, from reading to board games and crafts.
  • Socialize regularly. Social isolation and loneliness are linked to cognitive decline, so try to take part in social activities.
  • Prioritize sleep. Getting seven to eight hours of sleep each night can help ensure that your body and mind are getting the rest they need.
  • Prevent head injury. Since head injuries are linked to cognitive decline, it’s important to take steps to prevent them, such as assessing your home to prevent falls and wearing a seat belt in vehicles.
  • Don’t smoke. Smoking raises the risk for stroke and other forms of cardiovascular disease linked to dementia.
  • Limit alcohol. Drinking too much is linked to memory loss and may increase your risk of falling.
When it comes to food, following a high-quality diet that emphasizes plants may help limit cognitive decline. One approach that’s supported by research is the MIND diet, short for Mediterranean-DASH Intervention for Neurodegenerative Delay, which combines elements of the Mediterranean diet and the DASH diet.

Eating foods rich in substances called flavonoids may be especially helpful in preventing cognitive decline. Good sources of flavonoids include a range of fruits and vegetables, such as apples, pears, berries, oranges, peppers, and celery.

Supportive Care for Dementia

Nondrug treatments are often beneficial for people with dementia, and can take a number of forms.

Segal-Gidan says that managing medications can be especially challenging for people with dementia, so it’s important to get a system in place to make sure that people take their prescription drugs — from pill management tools to having someone come check on them.

Eventually, needing help with other activities is inevitable for most people with dementia. “Somewhere along the course of the disease, people need help to come into their home, or they need to be moved out of their home to a place where there is help,” says Segal-Gidan.

Other commonly prescribed or recommended nondrug therapies include the following:

  • Talk therapy with a mental health counselor or meetings with a support group can help people cope with the emotional challenges of their diagnosis.
  • Cognitive behavioral therapy helps people learn strategies that can help counter depression and anxiety.

  • Cognitive stimulation therapy keeps the mind active with themed activity sessions.

  • Occupational therapy helps people develop strategies for simplifying everyday tasks and making their home safer.

  • Palliative care can improve quality of life by suggesting ways to relieve symptoms.

  • Music therapy or aromatherapy can reduce anxiety and help improve mood.

  • Regular conversation and social contact with friends, family, and others benefits well-being. Some people might want to participate in a memory café.
  • Activities that a person already likes can continue to provide enjoyment. Some people might want to seek out new activities that are mentally stimulating.

People with Lewy body dementia in particular may benefit from the following kinds of therapy:

  • Physical therapy to address movement issues through cardiovascular, strengthening, and flexibility exercises
  • Speech therapy to help manage problems with voice projection or swallowing

For people with frontotemporal dementia who experience language problems, speech and language therapy may be helpful. The goal of this therapy is to make listening and speaking more effective, and it may involve focusing on certain words or using simpler, shorter sentences.

As frontotemporal dementia progresses, speech and language therapy may focus on communicating through gestures or drawings. It can also help with difficulty swallowing.

Noncognitive Treatments for Dementia

For many people with dementia, cognitive issues aren’t the only target of treatment. “You’re not just talking about cognition. You’re talking about behavior,” says Segal-Gidan. “Most of the drugs that we use are addressing these symptoms, whether that's depression or anxiety or psychosis.”

In early stages of Alzheimer’s disease, irritability, anxiety, or depression are common. In later stages of the disease, many people also experience aggression, agitation, hallucinations, or sleep disruption.

Drugs aren’t the only way to address noncognitive dementia symptoms. Changes to the home environment can encourage calm and peace of mind, and both behavioral and scheduling changes may help reduce sleep disruption.

Treatments for Underlying Issues

Certain health problems can contribute to cognitive decline, especially when it comes to cardiovascular issues and vascular dementia.

 Your doctor may prescribe treatments for the following conditions:
  • Hearing Loss Hearing loss can make it more difficult to interact with others and may increase the risk for cognitive decline.
  • High Blood Pressure High blood pressure is linked to vascular dementia, as well as stroke and other forms of cardiovascular disease linked to cognitive decline.
  • High Blood Sugar Elevated levels of blood sugar (glucose) in people with diabetes are linked to a greater dementia risk.

  • High Cholesterol Abnormal cholesterol or triglyceride levels can contribute to vascular dementia.
  • Blood Clot Risk If you’re at risk for a blood clot that could cause a stroke or heart attack, you may take medications to reduce this risk.

Treatments for Mood and Behavior

While mood and behavior changes are common in dementia, it’s important for any prescription drugs addressing them to be carefully considered — and to look at other ways to help reduce distress and otherwise improve the person’s life.

“Even with drugs, nonpharmacological approaches can be very effective” for mood and behavioral issues, says Segal-Gidan.

Nondrug approaches to mood and behavior issues may include the following:

  • Reducing physical obstacles or clutter in the home
  • Creating a calm environment without excess noise, glare, or distractions like a television in the background
  • Scheduling periods of rest between stimulating events
  • Providing a security object like a stuffed animal or blanket
  • Checking for issues like pain, hunger, thirst, constipation, a full bladder, or skin irritation
  • Remaining flexible and nonconfrontational in interactions with the person
The following types of drugs may be prescribed to help with mood or behavior changes in people with dementia:

  • Antidepressants to treat depression or irritability
  • Anxiolytics (antianxiety drugs) for anxiety, restlessness, or disruptive behavior
  • Antipsychotic medications for hallucinations, delusions, agitation, or aggressive behavior
Antipsychotic medications are linked to an increased risk of stroke and death in older adults with dementia and should be prescribed with extreme caution.

Traditional antipsychotic medications can be dangerous for people with Lewy body dementia, potentially causing severe confusion, extreme abnormal movements, sedation, or even death. Doctors may prescribe so-called atypical antipsychotic drugs at low doses for a limited time.

For people with frontotemporal dementia, both antidepressants and antipsychotic drugs can help with behavioral symptoms. But as in all cases, antipsychotic drugs should be used with extreme caution due to the increased risk of death.

Treatments for Sleep Problems

Dementia can cause difficulty falling or staying asleep (insomnia) as well as other changes, such as greater daytime sleepiness. Certain lifestyle and environmental changes may help with sleep:

  • Maintaining a regular sleep and mealtime schedule
  • Getting morning sunlight exposure
  • Exercising daily, but not within four hours before bed
  • Avoiding alcohol, caffeine, and nicotine
  • Maintaining a comfortable bedroom temperature
  • Using your bed only for sleep (not for television or reading)
  • Having night-lights to feel safe while in bed
One drug, suvorexant (Belsomra), has been approved to treat insomnia in people with Alzheimer’s disease. But other drugs may be used for sleep issues in people with dementia:

  • Tricyclic antidepressants
  • Benzodiazepines and other sedatives
  • Antipsychotic medications
One common symptom of Lewy body dementia is REM sleep behavior disorder, in which people physically act out their dreams. Clonazepam (Klonopin), a drug used for seizures and panic attacks, can reduce this symptom. The sleep hormone melatonin may also help on its own or in combination with clonazepam.

Treatments for Movement Issues in Lewy Body Dementia

People with Lewy body dementia usually develop movement symptoms such as muscle rigidity, a shuffling walk, and loss of muscle coordination. These symptoms may not occur until several years after cognitive symptoms begin.

A medication combining carbidopa and levodopa (Sinemet) can help people who have Lewy body dementia with walking and movements like getting out of bed. But it can cause hallucinations and other psychiatric problems, so it’s typically not used to treat mild symptoms.

Exercise and physical therapy may also help with movement symptoms in Lewy body dementia.

The Takeaway

  • Certain drugs can help treat cognitive symptoms in some forms of dementia, but they cannot reverse or stop cognitive decline.
  • Making changes to your routines and your home environment can help reduce frustration and improve quality of life with dementia.
  • Drugs and other treatments can help address noncognitive symptoms of dementia like behavioral changes and difficulty sleeping.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Dementia. Mayo Clinic. September 25, 2024.
  2. Medications for Memory, Cognition and Dementia-Related Behaviors. Alzheimer’s Association.
  3. Treatment Options. Lewy Body Dementia Association.
  4. Treatment and support for frontotemporal dementia. Alzheimer’s Society.
  5. Navigating Treatment Options. Alzheimer’s Association.
  6. Lifestyle Changes for Memory Loss. NYU Langone Health.
  7. Can I Prevent Dementia? Alzheimers.gov. July 9, 2024.
  8. Combination of Healthy Lifestyle Traits May Substantially Reduce Alzheimer’s Disease Risk. National Institute on Aging. June 17, 2020.
  9. Lifestyle Changes Can Help Prevent Dementia. Harvard T.H. Chan School of Public Health. August 9, 2021.
  10. Getting Treatment for Depression, Anxiety or Apathy. Alzheimer’s Society.
  11. Cognitive Stimulation Therapy (CST) and iCST. Saint Louis University School of Medicine.
  12. Malhi R et al. Palliative Care of the Patient With Dementia. Delaware Journal of Public Health. September 27, 2021.
  13. Person-Centred Care. Alzheimer’s Society.
  14. Treatments for Behavior. Alzheimer’s Association.
  15. Vascular Dementia. Mayo Clinic. July 29, 2021.
  16. Lewy Body Dementia: Causes, Symptoms, and Diagnosis. National Institute on Aging. January 27, 2025.
  17. Frontotemporal Dementia. Mayo Clinic. November 28, 2023.
  18. Treatments for Sleep Changes. Alzheimer’s Association.
jason-paul-chua-bio

Jason Paul Chua, MD, PhD

Medical Reviewer
Jason Chua, MD, PhD, is an assistant professor in the Department of Neurology and Division of Movement Disorders at Johns Hopkins School of Medicine. He received his training at the University of Michigan, where he obtained medical and graduate degrees, then completed a residency in neurology and a combined clinical/research fellowship in movement disorders and neurodegeneration.

Dr. Chua’s primary research interests are in neurodegenerative disease, with a special focus on the cellular housekeeping pathway of autophagy and its impact on disease development in diseases such as Parkinson disease. His work has been supported by multiple research training and career development grants from the National Institute of Neurological Disorders and Stroke and the American Academy of Neurology. He is the primary or coauthor of 14 peer-reviewed scientific publications and two peer-reviewed online learning modules from the American Academy of Neurology. He is also a contributing author to The Little Black Book of Neurology by Osama Zaldat, MD and Alan Lerner, MD, and has peer reviewed for the scientific journals Autophagy, eLife, and Neurobiology of Disease.
Pam-Kaufman-article

Pamela Kaufman

Author

Pamela Kaufman assigns and edits stories about infectious diseases and general health topics and strategizes on news coverage. She began her journalism career as a junior editor on the health and fitness beat at Vogue, followed by a long stint at Food & Wine, where she rose through the ranks to become executive editor. Kaufman has written for Rutgers University and Fordham Law School and was selected for a 2022 Health Journalism Fellowship from the Association of Health Care Journalists and the Centers for Disease Control and Prevention (CDC).

Kaufman enjoys going on restaurant adventures, reading novels, making soup in her slow cooker, and hanging out with her dog. She lives in New York City with her husband and two kids.